Jaka jest cena za BillionToOne, Inc. (BLLN)

Cena za BillionToOne, Inc. (BLLN) wynosi $99.89

Jaka jest kapitalizacja rynkowa dla BillionToOne, Inc. (BLLN)

Kapitalizacja rynkowa dla BillionToOne, Inc. (BLLN) wynosi $4.59B

BillionToOne, Inc. (BLLN) Stopa Dywidendy

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Rok	Stopa dywidendy	Zmień
Za mało danych dla podanych dat.

Rok

Stopa dywidendy

Zmień

Za mało danych dla podanych dat.

Firma	Stopa dywidendy	Kraj
Thermo Fisher Scientific Inc. TMO.US	0.31%	US
Danaher Corporation DHR.US	0.71%	US
WuXi AppTec Co., Ltd. 603259.SS	0.00%	CN
Natera, Inc. NTRA.US	0.00%	US
Agilent Technologies, Inc. A.US	0.68%	US

Firma

Stopa dywidendy

Kraj